THERALINK TECHNOLOGIES, INC.
company.status.inactiveCIK 1362703fmd_04NY6K74AW24PTAM5Y9JSH918RManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Mar 01, 2006 to Dec 31, 2023, 63 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2019 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | – | 0 | 1 | 1 | 1 |
| Rental revenue | – | – | – | – | – | – | – | – | 0 | – |
| Cost of revenue | – | – | – | – | – | – | 0 | 0 | 0 | 0 |
| Gross profit | – | – | – | – | – | – | 0 | 0 | 0 | 0 |
| Research and development | 0 | 0 | 0 | 0 | – | 0 | – | – | – | – |
| Selling, general and administrative | – | – | – | – | – | – | – | – | 0 | 0 |
| Compensation and benefits | – | – | – | – | – | – | – | – | – | – |
| Total operating expenses | 1 | 2 | 2 | 2 | – | – | 3 | 6 | 12 | 9 |
| Operating income | (1) | (2) | (2) | (2) | – | – | (3) | (6) | (12) | (9) |
| Interest expense | 0 | 0 | 1 | 2 | – | – | 0 | 0 | 1 | 17 |
| Other non-operating income (expense) | (0) | (0) | (12) | 8 | – | – | 0 | 0 | (1) | (22) |
| Income tax expense | – | – | – | – | – | – | – | – | – | – |
| Net income from continuing operations | – | (2) | (15) | 6 | – | (9) | – | – | – | – |
| Net income | (1) | (2) | (21) | 6 | – | – | (3) | (5) | (13) | (31) |
| Net income to common shareholders | – | – | – | – | (2) | – | (5) | (7) | (13) | (31) |